- 2014
-
Press releases - 14.11.2014
Avoiding skin graft rejection: it’s possible!
A research team bringing together José Cohen and Philippe Grimbert (Inserm Unit 955/Université Paris Est Créteil [UPEC] and the Centre for Clinical Investigation – Biotherapies 504 [CIC-BT 504]), and their collaborators at Institut Curie and AP-HP (George Pompidou European Hospital) has succeeded in finding a combination of drugs that reduces the risk of rejection following a skin graft. When tested in mice, this treatment seems effective, since no sign of rejection is observed nearly 30 days after transplantation.
-
Press releases - 13.11.2014
MSF and Inserm join their forces against Ebola : first trials
In the absence of specific treatments for Ebola, international medical humanitarian organisation Médecins Sans Frontières/Doctors Without Borders (MSF) announced today that it will host clinical trials in three Ebola treatment centres in West Africa.
-
What's on? - 13.11.2014
MSF and Inserm join their forces against Ebola : first trials
In the absence of specific treatments for Ebola, international medical humanitarian organisation Médecins Sans Frontières/Doctors Without Borders (MSF) announced today that it will host clinical trials in three Ebola treatment centres in West Africa. The separate trials, which are aimed at quickly finding an effective therapy that can be used against the disease which has […]
-
Press releases - 12.11.2014
November 14th 2014: World Diabetes Day
Initiated in 1991 by the International Diabetes Federation and World Health Organization, World Diabetes Day is aimed at making the general public aware and informed about prevention and management.
-
What's on? - 12.11.2014
November 14th 2014: World Diabetes Day
Diabetes type 1 or type 2 is a chronic disease caused by an insufficient mass of pancreatic beta cells, which produce insulin, or by poor use of this hormone by the body. This results in an elevated level of glucose in the bloodstream (hyperglycaemia), and may lead to serious complications (infarct, impaired vision, blindness, stroke, […]
-
Press releases - 10.11.2014
A means for autistic people to restore correct interpretation of sensory information
In autistic children, information coming from the 5 senses – touch, hearing, sight or other stimuli – are not correctly interpreted in the brain, leading to inappropriate behaviour and sometimes uncontrollable reactions. Inserm researchers led by Andréas Frick in Inserm Unit 862 ‘Magendie Neurocentre’ have recently understood why by studying a mouse model mimicking the disorder.
-
Press releases - 10.11.2014
Production of human motor neurons from stem cells is gaining speed
Researchers at the Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem – Inserm/AFM/UEVE) have recently developed a new approach to produce different populations of motor neurons from these cells in only 14 days.
-
Press releases - 31.10.2014
Lung cancer diagnosed before it is detected by imaging
A team of researchers from Inserm led by Paul Hofman (Inserm Unit 1081/University of Nice) has just made a significant advance in the area of early diagnosis of invasive cancers.
-
Press releases - 27.10.2014
October 29th 2014: World Stroke Day
World Cerebrovascular Accident Day is organised on 29 October each year and helps raise public awareness regarding the importance of immediate care for victims from onset of initial symptoms.
-
What's on? - 27.10.2014
October 29th 2014: World Stroke Day
Commonly referred to as a “stroke”, a Cerebrovascular Accident results from the interruption of blood flow to the brain. The deprivation of oxygen and essential nutrients causes brain cells to die, leading to permanent damage (speech or writing difficulty, memory problems, bodily paralysis to a greater or lesser extent), or even sudden death. World Cerebrovascular […]